EGFR and bronchopulmonary dysplasia: The underlying mechanism involved the NR4A1-EREG-EGFR pathway indicated that intervention with NR4A1 in utero or during the neonatal period could reduce the risk of BPD in offspring exposed to intrauterine inflammation.